Roy T. Eddleman, 10% Owner at REPLIGEN CORP (RGEN), sold 240,000 shares at $40.52 ($9.7M) on 2018-05-09, disclosed to the SEC on 2018-05-10.
Open-market sale of $9.7M RGEN by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $40.66 | 25,000 | $1.0M | 10.4% |
| 2 | $40.66 | 25,000 | $1.0M | 10.4% |
| 3 | $40.77 | 49,227 | $2.0M | 20.6% |
| 4 | $40.77 | 49,227 | $2.0M | 20.6% |
| 5 | $40.37 | 25,000 | $1.0M | 10.4% |
| 6 | $40.37 | 25,000 |
| $1.0M |
| 10.4% |
| 7 | $40.52 | 20,773 | $842K | 8.6% |
| 8 | $40.52 | 20,773 | $842K | 8.6% |
| Total | $40.62 avg | 240,000 | $9.7M | 100% |
| Filing → |
| RGEN | SELL | 2018-05-18 | $10.0M | — | Filing → |